PPD FSP Clinical Operations Solutions: The Evolution Of Clinical Operations And The Growth Of FSP Partnerships

The deployment of resources in clinical studies has always been essential, but the approach to utilizing these resources has evolved significantly over the years. Today, biopharmaceutical, biotech, and medical device organizations have a range of options for clinical monitoring and site management, including functional service provider (FSP) and full-service outsourcing (FSO) models, or a hybrid approach that combines elements of both. This evolution in resource management has allowed study sponsors to better address the complexities of clinical trials, ensuring the advancement of new medicines and medical devices.

This white paper delves into how clinical operations have adapted to meet the industry's most pressing challenges, with a particular focus on the growing popularity of the FSP model. It explores the factors driving the shift in staffing models, the rising dominance of FSPs in supporting on-time and on-budget trials, and the advantages of partnering with an FSP that has a global reach. Additionally, the paper discusses the integration of new technologies, the FSP’s role in promoting patient diversity, and how clinical operations leaders are increasingly becoming thought leaders within the industry.